Top compounds associated with response to TADA2B


Feature Type Standardized
Nominal ANOVA
mRNA GDC-0879 CTRPv2 pan-cancer AAC -0.084 0.02
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.02
mRNA ML239 CTRPv2 pan-cancer AAC -0.084 0.02
mRNA IU1 CTRPv2 pan-cancer AAC 0.091 0.02
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.02
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.068 0.02
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.08 0.02
mRNA AUY922 GDSC1000 pan-cancer AAC 0.079 0.02
mRNA Platin CTRPv2 pan-cancer AAC -0.087 0.02
mRNA AZ628 GDSC1000 pan-cancer AAC -0.11 0.02
Download CSV